The ephrin A1-EphA2 system promotes cardiac stem cell migration after infarction

Polina Goichberg, Yingnan Bai, Domenico D'Amario, João Ferreira-Martins, Claudia Fiorini, Hanqiao Zheng, Sergio Signore, Federica Del Monte, Sergio Ottolenghi, David A. D'Alessandro, Robert E. Michler, Toru Hosoda, Piero Anversa, Jan Kajstura, Marcello Rota, Annarosa Leri

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Rationale: Understanding the mechanisms that regulate trafficking of human cardiac stem cells (hCSCs) may lead to development of new therapeutic approaches for the failing heart. Objective: We tested whether the motility of hCSCs in immunosuppressed infarcted animals is controlled by the guidance system that involves the interaction of Eph receptors with ephrin ligands. Methods and Results: Within the cardiac niches, cardiomyocytes expressed preferentially the ephrin A1 ligand, whereas hCSCs possessed the EphA2 receptor. Treatment of hCSCs with ephrin A1 resulted in the rapid internalization of the ephrin A1-EphA2 complex, posttranslational modifications of Src kinases, and morphological changes consistent with the acquisition of a motile cell phenotype. Ephrin A1 enhanced the motility of hCSCs in vitro, and their migration in vivo following acute myocardial infarction. At 2 weeks after infarction, the volume of the regenerated myocardium was 2-fold larger in animals injected with ephrin A1-activated hCSCs than in animals receiving control hCSCs; this difference was dictated by a greater number of newly formed cardiomyocytes and coronary vessels. The increased recovery in myocardial mass with ephrin A1-treated hCSCs was characterized by further restoration of cardiac function and by a reduction in arrhythmic events. Conclusions: Ephrin A1 promotes the motility of EphA2-positive hCSCs, facilitates their migration to the area of damage, and enhances cardiac repair. Thus, in situ stimulation of resident hCSCs with ephrin A1 or their ex vivo activation before myocardial delivery improves cell targeting to sites of injury, possibly providing a novel strategy for the management of the diseased heart.

Original languageEnglish (US)
Pages (from-to)1071-1083
Number of pages13
JournalCirculation Research
Volume108
Issue number9
DOIs
StatePublished - Apr 29 2011

Fingerprint

Ephrin-A1
Infarction
Cell Movement
Stem Cells
Cardiac Myocytes
EphA2 Receptor
Human Trafficking
Eph Family Receptors
Ephrins
Ligands
src-Family Kinases
Post Translational Protein Processing
Disease Management

Keywords

  • cardiac stem cells
  • cell migration
  • ephrin
  • myocardial regeneration

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Goichberg, P., Bai, Y., D'Amario, D., Ferreira-Martins, J., Fiorini, C., Zheng, H., ... Leri, A. (2011). The ephrin A1-EphA2 system promotes cardiac stem cell migration after infarction. Circulation Research, 108(9), 1071-1083. https://doi.org/10.1161/CIRCRESAHA.110.239459

The ephrin A1-EphA2 system promotes cardiac stem cell migration after infarction. / Goichberg, Polina; Bai, Yingnan; D'Amario, Domenico; Ferreira-Martins, João; Fiorini, Claudia; Zheng, Hanqiao; Signore, Sergio; Del Monte, Federica; Ottolenghi, Sergio; D'Alessandro, David A.; Michler, Robert E.; Hosoda, Toru; Anversa, Piero; Kajstura, Jan; Rota, Marcello; Leri, Annarosa.

In: Circulation Research, Vol. 108, No. 9, 29.04.2011, p. 1071-1083.

Research output: Contribution to journalArticle

Goichberg, P, Bai, Y, D'Amario, D, Ferreira-Martins, J, Fiorini, C, Zheng, H, Signore, S, Del Monte, F, Ottolenghi, S, D'Alessandro, DA, Michler, RE, Hosoda, T, Anversa, P, Kajstura, J, Rota, M & Leri, A 2011, 'The ephrin A1-EphA2 system promotes cardiac stem cell migration after infarction', Circulation Research, vol. 108, no. 9, pp. 1071-1083. https://doi.org/10.1161/CIRCRESAHA.110.239459
Goichberg P, Bai Y, D'Amario D, Ferreira-Martins J, Fiorini C, Zheng H et al. The ephrin A1-EphA2 system promotes cardiac stem cell migration after infarction. Circulation Research. 2011 Apr 29;108(9):1071-1083. https://doi.org/10.1161/CIRCRESAHA.110.239459
Goichberg, Polina ; Bai, Yingnan ; D'Amario, Domenico ; Ferreira-Martins, João ; Fiorini, Claudia ; Zheng, Hanqiao ; Signore, Sergio ; Del Monte, Federica ; Ottolenghi, Sergio ; D'Alessandro, David A. ; Michler, Robert E. ; Hosoda, Toru ; Anversa, Piero ; Kajstura, Jan ; Rota, Marcello ; Leri, Annarosa. / The ephrin A1-EphA2 system promotes cardiac stem cell migration after infarction. In: Circulation Research. 2011 ; Vol. 108, No. 9. pp. 1071-1083.
@article{60753060c6474bcd9b8cc55d1e5d4040,
title = "The ephrin A1-EphA2 system promotes cardiac stem cell migration after infarction",
abstract = "Rationale: Understanding the mechanisms that regulate trafficking of human cardiac stem cells (hCSCs) may lead to development of new therapeutic approaches for the failing heart. Objective: We tested whether the motility of hCSCs in immunosuppressed infarcted animals is controlled by the guidance system that involves the interaction of Eph receptors with ephrin ligands. Methods and Results: Within the cardiac niches, cardiomyocytes expressed preferentially the ephrin A1 ligand, whereas hCSCs possessed the EphA2 receptor. Treatment of hCSCs with ephrin A1 resulted in the rapid internalization of the ephrin A1-EphA2 complex, posttranslational modifications of Src kinases, and morphological changes consistent with the acquisition of a motile cell phenotype. Ephrin A1 enhanced the motility of hCSCs in vitro, and their migration in vivo following acute myocardial infarction. At 2 weeks after infarction, the volume of the regenerated myocardium was 2-fold larger in animals injected with ephrin A1-activated hCSCs than in animals receiving control hCSCs; this difference was dictated by a greater number of newly formed cardiomyocytes and coronary vessels. The increased recovery in myocardial mass with ephrin A1-treated hCSCs was characterized by further restoration of cardiac function and by a reduction in arrhythmic events. Conclusions: Ephrin A1 promotes the motility of EphA2-positive hCSCs, facilitates their migration to the area of damage, and enhances cardiac repair. Thus, in situ stimulation of resident hCSCs with ephrin A1 or their ex vivo activation before myocardial delivery improves cell targeting to sites of injury, possibly providing a novel strategy for the management of the diseased heart.",
keywords = "cardiac stem cells, cell migration, ephrin, myocardial regeneration",
author = "Polina Goichberg and Yingnan Bai and Domenico D'Amario and Jo{\~a}o Ferreira-Martins and Claudia Fiorini and Hanqiao Zheng and Sergio Signore and {Del Monte}, Federica and Sergio Ottolenghi and D'Alessandro, {David A.} and Michler, {Robert E.} and Toru Hosoda and Piero Anversa and Jan Kajstura and Marcello Rota and Annarosa Leri",
year = "2011",
month = "4",
day = "29",
doi = "10.1161/CIRCRESAHA.110.239459",
language = "English (US)",
volume = "108",
pages = "1071--1083",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

TY - JOUR

T1 - The ephrin A1-EphA2 system promotes cardiac stem cell migration after infarction

AU - Goichberg, Polina

AU - Bai, Yingnan

AU - D'Amario, Domenico

AU - Ferreira-Martins, João

AU - Fiorini, Claudia

AU - Zheng, Hanqiao

AU - Signore, Sergio

AU - Del Monte, Federica

AU - Ottolenghi, Sergio

AU - D'Alessandro, David A.

AU - Michler, Robert E.

AU - Hosoda, Toru

AU - Anversa, Piero

AU - Kajstura, Jan

AU - Rota, Marcello

AU - Leri, Annarosa

PY - 2011/4/29

Y1 - 2011/4/29

N2 - Rationale: Understanding the mechanisms that regulate trafficking of human cardiac stem cells (hCSCs) may lead to development of new therapeutic approaches for the failing heart. Objective: We tested whether the motility of hCSCs in immunosuppressed infarcted animals is controlled by the guidance system that involves the interaction of Eph receptors with ephrin ligands. Methods and Results: Within the cardiac niches, cardiomyocytes expressed preferentially the ephrin A1 ligand, whereas hCSCs possessed the EphA2 receptor. Treatment of hCSCs with ephrin A1 resulted in the rapid internalization of the ephrin A1-EphA2 complex, posttranslational modifications of Src kinases, and morphological changes consistent with the acquisition of a motile cell phenotype. Ephrin A1 enhanced the motility of hCSCs in vitro, and their migration in vivo following acute myocardial infarction. At 2 weeks after infarction, the volume of the regenerated myocardium was 2-fold larger in animals injected with ephrin A1-activated hCSCs than in animals receiving control hCSCs; this difference was dictated by a greater number of newly formed cardiomyocytes and coronary vessels. The increased recovery in myocardial mass with ephrin A1-treated hCSCs was characterized by further restoration of cardiac function and by a reduction in arrhythmic events. Conclusions: Ephrin A1 promotes the motility of EphA2-positive hCSCs, facilitates their migration to the area of damage, and enhances cardiac repair. Thus, in situ stimulation of resident hCSCs with ephrin A1 or their ex vivo activation before myocardial delivery improves cell targeting to sites of injury, possibly providing a novel strategy for the management of the diseased heart.

AB - Rationale: Understanding the mechanisms that regulate trafficking of human cardiac stem cells (hCSCs) may lead to development of new therapeutic approaches for the failing heart. Objective: We tested whether the motility of hCSCs in immunosuppressed infarcted animals is controlled by the guidance system that involves the interaction of Eph receptors with ephrin ligands. Methods and Results: Within the cardiac niches, cardiomyocytes expressed preferentially the ephrin A1 ligand, whereas hCSCs possessed the EphA2 receptor. Treatment of hCSCs with ephrin A1 resulted in the rapid internalization of the ephrin A1-EphA2 complex, posttranslational modifications of Src kinases, and morphological changes consistent with the acquisition of a motile cell phenotype. Ephrin A1 enhanced the motility of hCSCs in vitro, and their migration in vivo following acute myocardial infarction. At 2 weeks after infarction, the volume of the regenerated myocardium was 2-fold larger in animals injected with ephrin A1-activated hCSCs than in animals receiving control hCSCs; this difference was dictated by a greater number of newly formed cardiomyocytes and coronary vessels. The increased recovery in myocardial mass with ephrin A1-treated hCSCs was characterized by further restoration of cardiac function and by a reduction in arrhythmic events. Conclusions: Ephrin A1 promotes the motility of EphA2-positive hCSCs, facilitates their migration to the area of damage, and enhances cardiac repair. Thus, in situ stimulation of resident hCSCs with ephrin A1 or their ex vivo activation before myocardial delivery improves cell targeting to sites of injury, possibly providing a novel strategy for the management of the diseased heart.

KW - cardiac stem cells

KW - cell migration

KW - ephrin

KW - myocardial regeneration

UR - http://www.scopus.com/inward/record.url?scp=79955593546&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955593546&partnerID=8YFLogxK

U2 - 10.1161/CIRCRESAHA.110.239459

DO - 10.1161/CIRCRESAHA.110.239459

M3 - Article

VL - 108

SP - 1071

EP - 1083

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 9

ER -